ITGR (Integer Holdings Corporation)
Insider Trading Activity
Every open-market purchase and sale reported by ITGR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Milo Stephen II Metcalf | US - EVP, Operations | A | — | — |
| 2026-07-01 | Kirk K Thor | Chief Human Resources Officer | MIXED | — | — |
| 2026-07-01 | John A Harris | President, Glob Ops & Manu Tec | A | — | — |
| 2026-05-22 | FILIPPO PASSERINI | Director | A | — | — |
| 2026-05-22 | Donald J Spence | Director | A | — | — |
| 2026-05-22 | James F. Hinrichs | Director | A | — | — |
| 2026-05-22 | Tommy P Thomas | VP, Corporate Controller | A | — | — |
| 2026-05-22 | Aaron Kapito | Director | A | — | — |
| 2026-05-22 | Sheila Antrum | Director | A | — | — |
| 2026-05-22 | James Francis Flanagan | Director | A | — | — |
| 2026-05-22 | Cheryl C Capps | Director | A | — | — |
| 2026-05-22 | Alvin Tyrone Jeffers | Director | A | — | — |
| 2026-05-22 | MARTIN C MAXWELL | Director | A | — | — |
| 2026-05-22 | MICHAEL J COYLE | Director | A | — | — |
| 2026-05-19 | Jim Stephens | President, CRM & Neuro | MIXED | — | — |
| 2026-05-12 | Diron Smith | EVP, Chief Financial Officer | MIXED | — | — |
| 2026-04-02 | John A Harris | EVP, Global Ops and Manufactur | MIXED | — | — |
| 2026-03-25 | Aaron Kapito | Director | A | — | — |
| 2026-03-25 | James Francis Flanagan | Director | A | — | — |
| 2026-03-25 | Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | MIXED | — | — |
| 2026-03-25 | Terence Carr | EVP, Qlty & Regulatory Affairs | MIXED | — | — |
| 2026-03-17 | Tommy P Thomas | VP, Corporate Controller | Sell | — | — |
| 2026-02-24 | Diron Smith | EVP, Chief Financial Officer | MIXED | — | — |
| 2026-02-24 | Andrew Senn | President, Cardio & Vascular | MIXED | — | — |
| 2026-02-24 | Tommy P Thomas | VP, Corporate Controller | MIXED | — | — |
| 2026-02-24 | Kirk K Thor | Chief Human Resources Officer | MIXED | — | — |
| 2026-02-24 | Jim Stephens | President, CRM & Neuro | MIXED | — | — |
| 2026-02-24 | Payman Khales | President & CEO | MIXED | — | — |
| 2026-01-21 | Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | A | — | — |
| 2026-01-21 | Terence Carr | EVP, Qlty & Regulatory Affairs | A | — | — |
| 2026-01-21 | Jim Stephens | President, CRM & Neuro | MIXED | — | — |
| 2026-01-21 | John A Harris | EVP, Global Ops and Manufactur | MIXED | — | — |
| 2026-01-21 | Kirk K Thor | Chief Human Resources Officer | MIXED | — | — |
| 2026-01-21 | Diron Smith | EVP, Chief Financial Officer | MIXED | — | — |
| 2026-01-21 | Tommy P Thomas | VP, Corporate Controller | MIXED | — | — |
| 2026-01-21 | Andrew Senn | SVP, Strategy and Business Dev | MIXED | — | — |
| 2026-01-21 | Payman Khales | President & CEO | MIXED | — | — |
| 2026-01-05 | PAMELA G BAILEY | Director | MIXED | — | — |
| 2025-12-16 | MARTIN C MAXWELL | Director | MIXED | — | — |
| 2025-11-13 | Tommy P Thomas | VP, Corporate Controller | Sell | — | — |
| 2025-11-13 | John A Harris | EVP, Global Ops and Manufactur | Buy | — | — |
| 2025-11-10 | Diron Smith | EVP, Chief Financial Officer | Buy | — | — |
| 2025-11-10 | Cheryl C Capps | Director | Buy | — | — |
| 2025-10-30 | Payman Khales | President & CEO | Buy | — | — |
| 2025-10-27 | Payman Khales | President & CEO | A | — | — |
| 2025-07-14 | MICHAEL J COYLE | Director | A | — | — |
| 2025-06-13 | Joseph W Dziedzic | President & CEO | MIXED | — | — |
| 2025-06-06 | Donald J Spence | Director | MIXED | — | — |
| 2025-06-06 | MARTIN C MAXWELL | Director | MIXED | — | — |
| 2025-05-23 | MARTIN C MAXWELL | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President & CEO | 330,060 | — |
| — | Director | 74,822 | — |
| — | Director | 62,745 | — |
| — | President & CEO | 59,202 | — |
| — | Director | 56,052 | — |
| — | Director | 44,410 | — |
| — | Chief Human Resources Officer | 41,102 | — |
| — | President & CEO | 40,377 | — |
| — | Sr. VP, Gen. Counsel & Sec. | 35,221 | — |
| — | Director | 31,114 | — |
| — | EVP, Global Operations & ESG | 26,457 | — |
| — | Director | 25,106 | — |
| — | SVP Strategy,Corp Dev., IR | 24,068 | — |
| — | Pres., Advanced Surgical, Orth | 20,285 | — |
| — | Director | 18,781 | — |
| — | EVP, COO | 16,514 | — |
| — | EVP, Chief Financial Officer | 16,103 | — |
| — | President, Cardio & Vascular | 13,880 | — |
| — | EVP, Quality & Regulatory Affa | 13,814 | — |
| — | Director | 13,669 | — |
| — | EVP, Chief Financial Officer | 13,421 | — |
| — | Director | 12,069 | — |
| — | EVP, Qlty & Regulatory Affairs | 10,033 | — |
| — | SVP, Gen Counsel & Secretary | 8,672 | — |
| — | President, Glob Ops & Manu Tec | 8,657 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ITGR quote page; the site-wide leaderboard is on the insider transactions hub.